Cleared Traditional

K091489 - CLEARVIEW ADVANCED STREP A

K091489 is the FDA 510(k) clearance for CLEARVIEW ADVANCED STREP A by Binax, Inc.. It is a Class 1 Microbiology device (product code GTY) cleared through the Traditional 510(k) pathway after a 107-day FDA review.

K091489 · Binax, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2009
Decision
107d
Days
Class 1
Risk

K091489 is an FDA 510(k) clearance for the CLEARVIEW ADVANCED STREP A , MODEL 737-430. Classified as Antigens, All Groups, Streptococcus Spp. (product code GTY), Class I - General Controls.

Submitted by Binax, Inc. (Scarborough, US). The FDA issued a Cleared decision on September 4, 2009 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Binax, Inc. devices

Submission Details

510(k) Number K091489 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 20, 2009
Decision Date September 04, 2009
Days to Decision 107 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
5d slower than avg
Panel avg: 102d · This submission: 107d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GTY Antigens, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTY Antigens, All Groups, Streptococcus Spp.

All 25
Devices cleared under the same product code (GTY) and FDA review panel - the closest regulatory comparables to K091489.
Healgen Strep A Rapid Test Strip (Throat Swab)
K212623 · Healgen Scientific, LLC · Mar 2022
WONDFO RAPID STREP A TEST
K133343 · Guangzhou Wondfo Biotech Co., Ltd. · Jan 2014
BD VERITOR(TM) SYSTEM FOR RAPID DETECTION OF GROUP A STREP
K122718 · Becton, Dickinson and Company · Feb 2013
BIOSTREP A, BIOSIGN STREP A, STATUSFIRST STREP A
K082661 · Princeton BioMeditech Corp. · Oct 2008
INVERNESS MEDICAL TESTPACK + PLUS STREP A WITH OBC
K051638 · Unipath , Ltd. · Dec 2005
STATUS FIRST STREP A
K040708 · Princeton BioMeditech Corp. · Nov 2004